Web Analytics
Cổ phiếu NTRA (NASDAQ) | NATERA INC – Phân tích Deepscope
MARKET

Select Market Data Region

NTRA — NATERA INC (Healthcare >> Diagnostics & Research)

NTRA FAQ

What is NTRA's P/E ratio?

NATERA INC (NTRA) currently trades at a P/E ratio of 652.50.

What is NTRA's ROE?

NATERA INC reports a Return on Equity (ROE) of -12.76%.

What is NTRA's dividend yield?

NATERA INC offers a dividend yield of 0.00%.

What is NTRA's Deepscope Quality Score?

Deepscope rates NTRA's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy NTRA?

Deepscope's AI Timing Score for NTRA is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does NTRA belong to?

NATERA INC is classified under the Healthcare >> Diagnostics & Research sector on the NASDAQ exchange.

Stock Check   *Daily update data at 9:30 AM*
(Price: 2026-06-05 | FS: 2026-03-31)

NTRA

NATERA INC
USD 215.31
-6.79 (-3.06%) Day Change
652.50
P/E
0.05
D/E
-12.8%
ROE
-8.7%
ROA
0.00%
Div Yield
-21.28
PEG
USD 215.31
Price
-6.79 (-3.06%)
Day Change
NEWS SCORE: 90

NTRA Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 31) nhưng Thời điểm mua ...(Sign In to See)...

31

QUALITY

Signal
UNDERPERFORM
Signal Description
Company financial health is Not Good
Reason
Tỷ lệ P/E tương đối cao
Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Lịch sử ROE tương đối thấp
ROA quá thấp so với ROE
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.

88 Sign in

TIMING

Signal
OUTPERFORM
Signal Descri...
Good
Reason
Lorem ipsum dolor sit amet
Sign in to see timing analysis
Unlock timing signals and detailed reasons
Sign in free

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt lắm , ...

Yếu tố Chất lượng 39%
X
X
X
X
  In Recommendations? Not in any sections
  Select Rate 0.00 From 30 days period
  Watch Rate 0.00 From 30 days period
  News Score 90
  Magic Formula Rank by ROA
N/A
  Magic Formula Rank by ROE
N/A
  Magic Formula Rank by ROIC
N/A
  Price 215.31
  PBV / Sector
17.38 / -23.44
  Earning Per Share -1.58
  PE / Sector
652.50 / 37.86
  PEG or PE/Growth / Sector
-21.28 / 1.41
  Average 1M Daily Value
337.08 M
GREAT
  Average 1W Daily Value
262.96 M
GREAT
Yếu tố Kỹ thuật 57%
  MACD
  MACD Signal
  MACD Divergence
  RSI
  Stochastic Oscillator K
  Stochastic Oscillator D
  ADX
  Avg 5 day Timing Score
Sức khỏe tài chính 45%
X
X
X
X
  DE / Sector
  DE Average / Sector
  DE Change Average (%) / Sector
  Current Ratio / Sector
  Current Ratio Average / Sector
  Current Ratio Change Average (%) / Sector
  Quick Ratio / Sector
  Quick Ratio Average / Sector
  Quick Ratio Change Average (%) / Sector
  FCF/Share / Sector
  FCF/Share Average / Sector
  FCF/Share Change Average (%) / Sector
Khả năng kiếm lợi nhuận 56%
X
X
X
X
X
X
X
  GPM (%) / Sector
  GPM Average (%) / Sector
  GPM Change Average (%) / Sector
  OPM (%) / Sector
  OPM Average (%) / Sector
  OPM Change Average (%) / Sector
  NPM (%) / Sector
-9.05 / 12.69
  NPM Average (%) / Sector
-27.25 / 7.99
  NPM Change Average (%) / Sector
-32.81 / -5.21
  Asset Turnover / Sector
  Asset Turnover Average / Sector
  Asset Turnover Change Average (%) / Sector
  ROA (%) / Sector
-8.66 / 11.23
  ROA Average (%) / Sector
-19.57 / -82.28
  ROA Change Average (%) / Sector
-27.13 / 159.98
  ROE (%) / Sector
-12.76 / -86.57
  ROE Average (%) / Sector
-35.06 / -2.21
  ROE Change Average (%) / Sector
-29.38 / -44.18
  ROIC (%) / Sector
  ROIC Average (%) / Sector
  ROIC Change Average (%) / Sector
Lợi tức cho nhà đầu tư 4%
X
  Dividend (%) / Sector
N/A / 0.26
  Dividend Average (%) / Sector
N/A / 1.20
  Dividend Change Average (%) / Sector
N/A / 7.47
Chi tiết đăng ký
X
  Analyze Date 2026-06-06 09:09:05
  Symbol NTRA
  Name NATERA INC
  Sector Healthcare >> Diagnostics & Research
  Market NASDAQ
  Listed Shares 143.22 M
  Par Value N/A
  Calculated From Quarter
  Sign N/A
  Market Cap (M.USD) / Sector Average 30,835.70 / 32,142.66
Tin tức, Dự báo ước tính
  Estimation Consensus See at WSJ.com
  Full details See at WSJ.com
  Chart See in Chart feature
  News See at Yahoo Finance

Address: 13011 McCallen Pass, Austin, TX, United States, 78753

Phone: 650 980 9190

Website: https://www.natera.com

Employees: 6,135

Sector: Healthcare >> Diagnostics & Research

Description: Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test. The company also provides Panorama, a non-invasive prenatal test; Horizon, a carrier screening test; Fetal Focus, a single-gene NIPT, or sgNIPT, that screens for 21 single-gene inherited conditions; and Vistara, a single-gene NIPT, which screens for 25 single-gene conditions. In addition, it offers Anora, which tests and analyzes miscarriage tissue from women who have experienced one or more pregnancy losses; Empower, a hereditary cancer screening test; Prospera, a test to assess active rejection in patients who have undergone solid organ transplantation; Renasight, a kidney gene panel test; and Constellation software, a cloud-based distribution model. Further, the company provides NateraCore, a platform to support the patient and provider experience; phlebotomy services; and EMR integration services. The company serves independent laboratories, national and regional reference laboratories, medical centers and physician practices for its screening tests, research laboratories, and pharmaceutical companies through its direct sales force and laboratory distribution partners, as well as Constellation licensees under its cloud-based distribution model. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays for clinical and commercial use. The company has a collaboration with Diakonos Oncology Corp. to assess molecular response in patients with refractory melanoma. The company was formerly known as Gene Security Network, LLC and changed its name to Natera, Inc. in Januar

ME vs SECTOR Healthcare >> Diagnostics & Research

NTRA (ME)
Sector Peers
Bubble size = Market Cap

Click a bubble to view stock details  ·  Bubble size represents market capitalization share

News

Smart picks. Just WOW stocks/funds/ETFs. No noise like other tools.
NTRA
NTRA
USD 215.31 (-3.06%)
+ Watch + Port Chart